menu Home

Program

  • DAY 1 / March 8(Fri)
  • DAY 2 / March 9(Sat)

DAY 1 / March 8(Fri). 2024

SC Convention Anais Hall (12F), Seoul, Korea

Master of Ceremonies: Seo Yeon LEE (Korea)

Time Program Chair / Speaker
13:00-13:10 Opening Remarks Sung Kyu HONG (President, KPS)
Jun Hyuk HONG (President, KUA)
13:10-14:30 Session I: New Advancements in the Staging Workup of Prostate Cancer Byung Ha CHUNG (Korea)
Jae Il CHUNG (Korea)
13:10-13:30 Biomarkers and Imaging in prostate cancer diagnosis and risk stratification Behfar EHDAIE (USA)
13:30-13:50 PSMA PET imaging for prostate cancer diagnosis and selection of candidates for AS Nathan LAWRENTSCHUK (Australia)
We are ready to change management based on PSMA  
13:50-14:00 1) Yes Jong Kil NAM (Korea)
14:00-14:10 2) No Sungchan PARK (Korea)
14:10-14:30 Panel Discussion Jae Seung CHUNG (Korea)
Jin Kyu OH (Korea)
See Min CHOI (Korea)
Yoo Sung SONG (Korea)
Sang Hun SONG (Korea)
14:30-16:00 Session II: Navigating Pre and Post-care Essentials Around Prostate Disease Kyung Seop LEE (Korea)
14:30-14:40 PSA screening: is it beneficial especially in asian countries? Young Hwii KO (Korea)
14:40-15:00 Biopsy techniques: transperineal, transrectal, or avoiding biopsy Behfar EHDAIE (USA)
15:00-15:20 Individualized treatment of BPH Stavros GRAVAS (Greece)
15:20-15:40 Surgical technique and recovery of urinary incontinence after radical prostatectomy Rafael SANCHEZ-SALAS (Canada)
15:40-16:00 Panel Discussion Hwang Gyun JEON (Korea)
Se Yun KWON (Korea)
Seo Yeon LEE (Korea)
Junghoon LEE (Korea)
16:00-16:20 Coffee Break
16:20-17:40 Session III: Does Recent Advancements Offer Opportunities to Optimize Patients with mHSPC ? Choung Soo KIM (Korea)
Chang Wook JEONG (Korea)
16:20-16:40 Androgen receptor directed therapy in the contemporary era Daniel DANILA (USA)
16:40-16:50 Treatment options for mHSPC, advances and barriers Taek Sang KIM (Korea)
16:50-17:00 What is the optimal target for radiotherapy? Primary only, primary plus nodes, primary plus nodes plus metastases? Byung Hoon KIM (Korea)
17:00-17:10 Can genomic information assist in treatment decisions in the management of mHSPC? Hyun Chul CHUNG (Korea)
17:10-17:40 Case-Based Panel Discussion : Presentation Case 1, 2 Soodong KIM (Korea)
Sung Dae KIM (Korea)
Jongwook PARK (Korea)
Hyung Joon KIM (Korea)
17:40-18:00 Satellite Symposium - Astellas Jun Sung KOH (Korea)
Early treatement intensification with Enzalutamide in mHSPC Jong Wook KIM (Korea)
18:10 Welcome Dinner  

DAY 2 / March 9(Sat). 2024

SC Convention International Conference Hall (B1F), Seoul, Korea

Master of Ceremonies: Seo Yeon LEE (Korea)

Time Program Chair / Speaker
09:00-10:00 Podium Session Moon Ki JO (Korea)
Yun Beom KIM (Korea)
10:00-11:10 Session IV: How to Best Manage Patients with High-risk Localized and Locally Advanced Prostate Cancer? Sung Kyu HONG (Korea)
Jacob See-Tong PANG (Taiwan)
10:00-10:10 Surgery as radical local treatment (as part of a multimodality approach) Jung Ki JO (Korea)
10:10-10:20 Radiation therapy as radical local treatment (as part of a multimodality approach) Kyo Chul KOO (Korea)
10:20-10:40 Neoadjuvant Lutetium therapy before RP in high risk PCa patients Nathan LAWRENTSCHUK (Australia)
10:40-11:10 Case-Based Panel Discussion : Presentation Case 1, 2 Yu Seob SHIN (Korea)
Se Young CHOI (Korea)
Dong Hyuk KANG (Korea)
Jongsoo LEE (Korea)
11:10-11:25 Coffee Break
11:25-12:45 Session V: Focal Therapy: Are We Ready to Change the Prostate Cancer Treatment Paradigm? Ji Youl LEE (Korea)
Peter Ka Fung CHIU (Hong Kong)
11:25-11:45 A quest for consensus on focal therapy for prostate cancer Rafael SANCHEZ-SALAS (Canada)
11:45-12:05 Focal therapy in prostate cancer: Friend or Foe Behfar EHDAIE (USA)
12:05-12:15 How should clinicians confirm if a patient is a candidate for focal therapy and define successful treatment? Hakmin LEE (Korea)
12:15-12:45 Case-Based Panel Discussion : Presentation Case 1, 2 Tae Hyo KIM (Korea)
Phil Hyun SONG (Korea)
Jeong Woo LEE (Korea)
Dongho SHIN (Korea)
12:45-13:45 Luncheon Symposium and Lunch - Janssen Sung Kyu HONG (Korea)
Optimal choice in the 1st line mHSPC treatment with apalutamide Hyunho HAN (Korea)
13:45-14:00 Special Session: Prostate International  
Prostate International: past, present, and future Jae Seung CHUNG (Korea)
14:00-15:20 Session VI: Management of mCRPC Seong Il SEO (Korea)
Takashi KOBAYASHI (Japan)
14:00-14:20 CRPC: How to best sequence therapies in real life Daniel DANILA (USA)
14:20-14:30 Current role of PSMA-based radioligand therapy for mCRPC Yong Hyun PARK (Korea)
  The advent of PARP inhibitors for specific to all-comer application  
14:30-14:40 1) only for specific patients Wan SONG (Korea)
14:40-14:50 2) for all-comer patients Jae Young JOUNG (Korea)
14:50-15:20 Case-Based Panel Discussion : Presentation case 1, 2 Jongwook PARK (Korea)
Won Tae KIM (Korea)
Hongzoo PARK (Korea)
15:20-15:35 Coffee Break
15:35-16:35 Session VII: BPH Surgery, Beyond Current Method Tag Keun YOO (Korea)
15:35-15:45 Laser and robotics enucleastion Sang Hoon SONG (Korea)
15:45-15:55 Vaporization and aqua-ablation Myong KIM (Korea)
15:55-16:15 Should we abandon TURP? Stavros GRAVAS (Greece)
16:15-16:35 Panel Discussion Doosang KIM (Korea)
Hyoung Keun PARK (Korea)
Kyung Jin CHUNG (Korea)
Jae Hyun RYU (Korea)
16:35-16:40 Closing Remarks Sung Kyu HONG (President, KPS)
go to top

Copyright(C) by 2024 KPS Annual Prostate International Meeting.
All rights reserved.

Secretariat of KPS

Gaon Convention Services, Inc.
ADDRESS: ROOM 301, 347, HWAGOK-RO, GANGSEO-GU, SEOUL, REPUBLIC OF KOREA.
TEL : +82-2-6956-7989   |   E-MAIL : gaonpco@gaonpco.com

close

사전등록

등록구분
근무처
소속의사회

* 의사 회원인 경우에는 연수평점 카드 기록을 위해서 필요 합니다.